DexTech Medical Overview
- Founded
-
2004
- Status
-
Public
- Employees
-
1
- Stock Symbol
-
DEX
- Share Price
-
$0.47
- (As of Friday Closing)
DexTech Medical General Information
Description
DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases.
Contact Information
Primary Industry
Drug Discovery
Stock Exchange
SAT
Primary Office
- Box 389
- 751 06 Uppsala
- Sweden
+46 070-710 00 00
DexTech Medical Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.47 | $0.47 | $0.40 - $3.85 | $8.74M | 18.5M | 9.4K | -$0.03 |
DexTech Medical Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 |
|---|---|---|---|---|
| EV | 16,935 | 61,447 | 77,681 | 124,352 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (213) | (227) | (217) | (146) |
| Net Income | (533) | (708) | (800) | (913) |
| Total Assets | 4,441 | 848 | 1,430 | 2,418 |
| Total Debt | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
DexTech Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DexTech Medical Patents
DexTech Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2011516508-A | Modified hydroxypolymer conjugates with bone accumulation and tumoricidal moieties | Granted | 07-Apr-2008 | 0000000000 | |
| EP-2274018-A1 | Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties | Granted | 07-Apr-2008 | 0000000000 | |
| CA-2719295-C | Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties | Active | 07-Apr-2008 | 0000000000 | |
| CA-2719295-A1 | Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties | Granted | 07-Apr-2008 | 0000000000 | |
| US-20110118207-A1 | Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties | Abandoned | 07-Apr-2008 | A61K51/065 |
DexTech Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
